Trinity Biotech 400-5-1000
by Trinity Biotech Public Limited Company
Trinity Biotech 400-5-1000 is a medical device (FDA Class II; FDA product code JBG, Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Spot) made by Trinity Biotech Public Limited Company, listed in FDA GUDID since 6 Oct 2017 (UDI-DI 05391516741699), registry data as of 23 Oct 2026.
Listed
Valid until
Not applicable
FDA recalls
Not checked
Documents
None
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number05391516741699 | Date6 Oct 2017 | StatusListed |
Official records
- AccessGUDID record 05391516741699
From the FDA record
- Device description
- Mineral Oil
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Trade name
- Trinity Biotech
- Generic name
- Red cell glucose-6-phosphate dehydrogenase (G6PD) IVD, reagent
- Model / Ref / Catalog
- 400-5-1000
- Primary DI / UDI-DI
- 05391516741699
- FDA product code
- JBG
- GMDN term
- Red cell glucose-6-phosphate dehydrogenase (G6PD) IVD, reagent
- Device class
- Class II
- Regulation number
- 864.7360
- GUDID distribution status
- In Commercial Distribution
- Size
- Total Volume — 1000 Milliliter
Other devices from Trinity Biotech Public Limited Company
See all devices from Trinity Biotech Public Limited Company →